Ropard's History
Founded in 1990 by a concerned group of physicians and volunteers,
ROPARD is the first organization in the country dedicated to eliminating
the problems of low vision and blindness in children caused by premature
birth and retinal disease.
ROPARD's primary goal has been the funding of clinically relevant
research to understand, treat, and prevent retinopathy of prematurity
and related retinal diseases. It is supported solely by private
contributions administered by its Board of Trustees.
ROPARD has funded research at Oakland University's Eve Research
Institute, the Mayo Clinic, and Johns Hopkins University.
It has established a pediatric retinal rescue lab at William Beaumont
Hospital in Royal Oak, Michigan.
ROPARD research has begun to identify a genetic link between
premature birth and retinal detachment.
ROPARD's accomplishments are made possible by the continuing support
of responsive and generous individuals. Expanding lab facilities,
exploring new therapeutic interventions, and further genetic research
continue to be our primary objectives. ROPARD funds researchers who
submit competitive grant requests to be reviewed by a research committee
and approved by the Board of Trustees.
You can make a difference. To make a tax deductible contribution
which will be used to support the highest levels of clinically relevant
research, contact ROPARD.
For information about your child's ocular problems, contact your eye
professional. ROPARD does not make referrals to specific physicians.
|
